Abiopharma

News list

Director CULLEN JAMES 🟢 acquired 870 shares of Keysight Technologies, Inc. (KEYS) Transaction Date: Mar 20, 2026 | Filing ID: 000002

Full text

News bot March 24, 2026, 10:09 a.m.
🔍 CULLEN JAMES (Director)

Company: Keysight Technologies, Inc. (KEYS)

Report Date: 2026-03-20
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 870
Detailed Transactions and Holdings:
- Acquired 870 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 24,821.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Common stock underlying restricted stock units ("RSUs") granted pursuant to the 2014 Equity and Incentive Compensation Plan. The RSUs vested immediately.